FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION THAT EFFEXOR XR (VENLAFAXINE HYDROCHLORIDE) EXTENDED-RELEASE CAPSULE, 100 MILLIGRAMS, WAS NOT WITHDRAWN FROM SALE FOR REASONS OF SAFETY OR EFFECTIVENESS

WASHINGTON, Dec. 19 -- Food and Drug Administration has issued a notice called: Determination That EFFEXOR XR (Venlafaxine Hydrochloride) Extended-Release Capsule, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness.

The notice was published in the Federal Register on Dec. 19 by Lowell M. Zeta, Acting Deputy Commissioner for Policy, Legislation, and International Affairs.

Summary: The Food and Drug Administration (FDA or Agency) has determined that EFFEXOR XR (venlafaxine hydrochloride) extended-release capsule, 100 milligrams (mg), was not withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug appli...